QDEL

10.54

0.52% -0.055

Dopo l'orario di chiusura: 10.54

Quidelortho Corp (QDEL)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Forum Previsione

Precedente Chiudi:

$10.60

Aprire:

$10.64

Volume 24 ore:

1.38M

Relative Volume:

0.91

Capitalizzazione di mercato:

$722.79M

Reddito:

$2.66B

Utile/perdita netta:

$-1.21B

Rapporto P/E:

-0.5915

EPS:

-17.82

Flusso di cassa netto:

$-159.40M

1 W Prestazione:

+1.93%

1M Prestazione:

-26.96%

6M Prestazione:

-35.85%

1 anno Prestazione:

-64.21%

Intervallo 1D:

$10.34

$10.64

Intervallo di 1 settimana:

$10.34

$11.10

Portata 52W:

$9.92

$35.58

Quidelortho Corp Stock (QDEL) Company Profile

Nome

Quidelortho Corp

Settore

Healthcare (1062)

Industria

Medical Devices (138)

Telefono

(858) 552-1100

Indirizzo

9975 SUMMERS RIDGE ROAD, SAN DIEGO, CA

Dipendente

6,500

Cinguettio

@QuidelDX

Prossima data di guadagno

2026-11-04

Ultimi documenti SEC

QDEL's Discussions on Twitter

Compare QDEL vs ABT, MDT, SYK, BSX, EW

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
QDEL Quidelortho Corp	10.54	750.22M	2.66B	-1.21B	-159.40M	-17.82
ABT Abbott Laboratories	98.83	175.27B	46.59B	5.41B	7.38B	3.0938
MDT Medtronic Plc	86.29	113.38B	36.36B	4.84B	5.43B	3.7261
SYK Stryker Corp	275.39	104.47B	25.27B	3.34B	4.57B	8.6334
BSX Boston Scientific Corp	43.65	63.65B	20.62B	3.56B	3.48B	2.3847
EW Edwards Lifesciences Corp	86.32	49.74B	6.30B	1.07B	1.09B	1.8406

Quidelortho Corp Stock (QDEL) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2025-10-07	Downgrade	Citigroup	Buy → Neutral
2025-05-08	Aggiornamento	Jefferies	Hold → Buy
2024-12-11	Aggiornamento	Citigroup	Neutral → Buy
2024-12-10	Iniziato	Jefferies	Hold
2024-09-19	Ripresa	UBS	Neutral
2024-09-05	Aggiornamento	Craig Hallum	Hold → Buy
2024-03-04	Downgrade	UBS	Neutral → Sell
2024-02-14	Downgrade	JP Morgan	Neutral → Underweight
2023-12-11	Downgrade	Citigroup	Buy → Neutral
2022-12-12	Aggiornamento	Citigroup	Neutral → Buy
2022-12-07	Iniziato	RBC Capital Mkts	Outperform
2022-10-14	Aggiornamento	UBS	Sell → Neutral
2022-09-19	Iniziato	Citigroup	Neutral
2022-07-20	Iniziato	UBS	Sell
2022-06-17	Ripresa	JP Morgan	Neutral
2022-02-22	Aggiornamento	Raymond James	Outperform → Strong Buy
2021-01-22	Aggiornamento	Raymond James	Mkt Perform → Outperform
2020-05-12	Downgrade	JP Morgan	Neutral → Underweight
2020-03-26	Downgrade	Barclays	Overweight → Equal Weight
2018-10-23	Ripresa	Raymond James	Strong Buy
2018-03-08	Aggiornamento	Raymond James	Outperform → Strong Buy
2018-01-22	Reiterato	Barclays	Overweight
2018-01-04	Aggiornamento	CL King	Neutral → Buy
2017-09-19	Aggiornamento	Piper Jaffray	Neutral → Overweight
2017-07-18	Aggiornamento	Canaccord Genuity	Hold → Buy
2017-07-18	Aggiornamento	William Blair	Mkt Perform → Outperform
2017-04-25	Reiterato	Canaccord Genuity	Hold
2017-02-17	Iniziato	CL King	Neutral
2016-12-16	Downgrade	Piper Jaffray	Overweight → Neutral
2016-06-13	Aggiornamento	Raymond James	Mkt Perform → Outperform
2016-02-18	Reiterato	Barclays	Overweight
2016-02-09	Downgrade	Canaccord Genuity	Buy → Hold
2016-01-08	Reiterato	Canaccord Genuity	Buy
2015-12-14	Downgrade	Raymond James	Outperform → Mkt Perform
2015-09-02	Iniziato	Barclays	Overweight
2013-07-31	Reiterato	Canaccord Genuity	Buy
2011-03-03	Downgrade	Wedbush	Outperform → Neutral

Mostra tutto

Quidelortho Corp Borsa (QDEL) Ultime notizie

Sep 26, 2026

QuidelOrtho Corporation (QDEL) Stock Forecasts - Yahoo! Finance Canada

Sep 26, 2026

Quidel Corporation (QDEL) stock price, news, quote and history - Yahoo Finance UK

Sep 26, 2026

Sep 24, 2026

QuidelOrtho Corporation (QDEL) Stock forecasts - Yahoo Finance UK

Sep 24, 2026

QuidelOrtho Corporation (QDEL) Stock Price, News, Quote & History - ca.finance.yahoo.com

Sep 24, 2026

Early Intervention Aids Emergency Medicine Teams in Identifying and Personalizing Sepsis Treatment - Financial Times

Sep 24, 2026

Sep 23, 2026

A Look at QuidelOrtho Corp (QDEL) After 5.5% Decline -- GF Value $33.09 vs Price $10.34 - GuruFocus

Sep 23, 2026

QuidelOrtho Updates Credit Agreement, Revises Financial Covenants Through 2029 - Kalkine Media

Sep 23, 2026

Surgery Partners, 10x Genomics, QuidelOrtho, Zimmer Biomet, and Tandem Diabetes Stocks Trade Down, What You Need To Know - Yahoo Finance

Sep 23, 2026

Quidelortho Corp Enters Amendment No. 1 To Credit Agreement On Sept 23, 2026 - TradingView

Sep 23, 2026

QuidelOrtho Corporation Enters Into Amendment No. 1 To Existing Credit Agreement - marketscreener.com

Sep 23, 2026

Sep 11, 2026

Is QuidelOrtho Corp (QDEL) a Bargain After 3.1% Drop? GF Value S - GuruFocus

Sep 11, 2026

Sep 05, 2026

QDEL stock gains as QuidelOrtho beats estimates and trades near target - ad-hoc-news.de

Sep 05, 2026

Aug 27, 2026

Respiratory test results can arrive in as little as six minutes - Stock Titan

Aug 27, 2026

Aug 21, 2026

QuidelOrtho (NASDAQ:QDEL) Stock Price Down 3.4%Should You Sell? - MarketBeat

Aug 21, 2026

Tejara Capital Ltd Takes $2.27 Million Position in QuidelOrtho Corporation $QDEL - MarketBeat

Aug 21, 2026

Aug 20, 2026

QuidelOrtho (NASDAQ:QDEL) Shares Up 6.9%Here's What Happened - MarketBeat

Aug 20, 2026

QDEL Stock Eyes Best Day In Over A Year — Point-Of-Care Sale Talks Ignite Rally - Stocktwits

Aug 20, 2026

Aug 18, 2026

QuidelOrtho Corporation’s Margin Recovery Meets China, Respiratory & Cash Flow Headwinds ! - Smartkarma

Aug 18, 2026

QuidelOrtho EVP Bryan Hanson Reports RSU Vesting and Tax-Related Share Withholding - Kalkine Media

Aug 18, 2026

QuidelOrtho (QDEL) Q2 2026 Earnings Call Transcript - AOL.com

Aug 18, 2026

QuidelOrtho (QDEL) Earnings Check: Reported EPS Tops Expectations for the Current Session; Market Follow-Through: Shares Close 8.44% LowerLow Estimate Range - Vinanet

Aug 18, 2026